Retinal Microvascular Dysfunction and Related Diseases

A special issue of Vision (ISSN 2411-5150). This special issue belongs to the section "Retinal Function and Disease".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 1962

Special Issue Editor


E-Mail Website
Guest Editor
1. Vascular Research Laboratory, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK
2. Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, UK
Interests: retinal vascular imaging; cardiovascular disease; retinal vascular function

Special Issue Information

Dear Colleagues,

Because they can be readily imaged in living patients, retinal vessels are well studied in both health and disease. This is important because retinal vessels’ structure and function are affected by a large number of pathologies, from ocular to systemic. In particular, since recent technical developments have significantly improved our abilities to assess the function of these vessels as well as retinal perfusion, we are able to gain a better insight into the pathophysiology of such diseases. This Special Issue aims to collect articles focused on recent advancements in the use of retinal vascular function and retinal perfusion parameters to assess early risk and facilitate the diagnosis and follow-up of various ocular and systemic diseases. Review articles, original research papers and case studies are all welcome.

Dr. Doina Gherghel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vision is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 414 KiB  
Review
Combined Branch Retinal Artery and Central Retinal Vein Occlusion: A Systematic Review
by Antonio Pinna, Angelo Zinellu, Rita Serra, Giacomo Boscia, Lorenza Ronchi and Stefano Dore
Vision 2023, 7(3), 51; https://doi.org/10.3390/vision7030051 - 28 Jul 2023
Cited by 2 | Viewed by 1506
Abstract
We performed a systematic review and analyzed the current available data on branch retinal artery occlusion (BRAO) with simultaneous central retinal vein obstruction (CRVO), a rarely described occurrence. MEDLINE/PubMed and ISI Web of Sciences searches were performed according to MOOSE guidelines. Studies were [...] Read more.
We performed a systematic review and analyzed the current available data on branch retinal artery occlusion (BRAO) with simultaneous central retinal vein obstruction (CRVO), a rarely described occurrence. MEDLINE/PubMed and ISI Web of Sciences searches were performed according to MOOSE guidelines. Studies were considered eligible if they (1) described patients with simultaneous BRAO + CRVO and (2) had been published in peer-reviewed journals. We initially identified 239 records from databases. Ultimately, only 19 reports met the selection criteria. Twenty-nine patients (15 men, 14 women; mean age 43 ± 15 years) were analyzed. Seventeen (59%) patients presented vascular risk factors. Mean visual acuity at onset and final visual outcome were 20/83 and 20/45, respectively, an insignificant improvement. Vision improved in 48% of cases. A marked heterogeneity in treatment approach was found. Eight (28%) patients received no therapy, whereas for 21 (72%) a large variety of topical and/or systemic drugs was given. In the treated group, mean visual acuity at onset and final visual outcome were 20/90 and 20/44, respectively, a not statistically significant improvement. Results suggest that combined BRAO + CRVO occurs at a younger age than isolated BRAO or CRVO. At present, there is insufficient evidence to support any specific management to improve vision in simultaneous BRAO + CRVO. Full article
(This article belongs to the Special Issue Retinal Microvascular Dysfunction and Related Diseases)
Show Figures

Figure 1

Back to TopTop